BCR signaling is a central pathologic mechanism in B-cell malignancies, including chronic lymphocytic leukemia (CLL), diffuse large B-cell lymphoma (DLBCL) (Davis et al., 2010), and mantle cell lymphoma (MCL). This evidence concerns the gene BCR and diffuse large B-cell lymphoma.